Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bayer Ag ADR (OP:BAYRY)

11.81 +0.22 (+1.87%)
Streaming Delayed Price Updated: 9:30 AM EDT, Apr 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag ADR

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Record-Breaking US Soybean Planting Pace Clouds Futures Market
The United States Department of Agriculture (USDA) sent ripples through the commodities markets this week with the release of its latest Crop Progress report, revealing that U.S. soybean planting has... 
Via MarketMinute
Topics Economy Energy World Trade
News headline image
Midwest Planting Delays Loom as NOAA Predicts Heavy April Rains
As the mid-April sun typically signals the start of the heavy planting season across the American heartland, the 2026 season is proving to be a frustrating exercise in patience. Farmers across the Corn... 
Via MarketMinute
News headline image
USDA Stuns Markets as April WASDE Raises Farm Gate Prices Amid Domestic Supply Crunch
The United States Department of Agriculture (USDA) sent shockwaves through the agricultural sector this morning with the release of the April 2026 World Agricultural Supply and Demand Estimates (WASDE)... 
Via MarketMinute
Topics Economy Energy
News headline image
Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential
From Bayer
Via Business Wire
News headline image
Multiplatinum Rapper, Actor Ludacris Partners with One A Day® to Help People Realize that Health Does Not Need to Be Ludacris
From Bayer
Via Business Wire
News headline image
The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush
As of March 18, 2026, the corporate landscape has undergone a radical transformation. The era of the sprawling global conglomerate, once the gold standard of industrial stability, is rapidly giving way... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease
From Bayer
Via Business Wire
News headline image
New FDA 510(k) Clearance Expands Bayer’s MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments
From Bayer
Via Business Wire
News headline image
The Section 122 Pivot: How a 10% Global Tariff is Reshaping the 2026 Market Landscape
The global financial markets have entered a period of profound "legalized volatility" following the White House’s emergency invocation of Section 122 of the Trade Act of 1974. This move, triggered by a... 
Via MarketMinute
Topics Economy Electric Vehicles Government
News headline image
The Strategic Crossroads of FMC Corporation: A 2026 Research Deep Dive
Date: March 3, 2026 Introduction FMC Corporation (NYSE: FMC) currently finds itself at one of the most pivotal junctures in its 140-year history. Once a darling of the agricultural sector known for its... 
Via Finterra
Topics Economy Intellectual Property World Trade
News headline image
The Great Grain Pivot: USDA Forecasts Record Soy Surge as Corn Retreats in 2026
The American agricultural landscape is undergoing a massive structural shift as the 2026 planting season approaches. According to the U.S. Department of Agriculture's (USDA) 102nd Agricultural Outlook... 
Via MarketMinute
Topics Energy
News headline image
Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
From Bayer
Via Business Wire
News headline image
Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases
From Bayer
Via Business Wire
News headline image
European Commission Grants Marketing Authorization to Cytokinetics for Cardiac Drug MYQORZO
In a landmark decision for the cardiovascular treatment landscape, the European Commission (EC) officially granted marketing authorization to Cytokinetics, Inc. (Nasdaq: CYTK) on February 17, 2026, for... 
Via MarketMinute
Topics Intellectual Property
News headline image
Bayer Alleges J&J’s Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADA
From Bayer
Via Business Wire
News headline image
Bayer's $7.25 Billion Roundup Settlement: A 21-Year Plan for Certainty
Bayer AG (OTC: BAYRY) has announced a sweeping $7.25 billion proposed class action settlement aimed at resolving the vast majority of its remaining U.S. litigation involving the weedkiller Roundup.... 
Via MarketMinute
Topics Lawsuit
News headline image
Uncle Sam’s $44.36 Per Acre Gamble: How Government Intervention is Distorting the 2026 Planting Season
As the 2026 planting season approaches, American farmers are facing a paradox of record-low commodity prices and unprecedented government support. The centerpiece of this intervention is the newly... 
Via MarketMinute
Topics Economy
News headline image
German Pharma Giant Bayer Proposes $7.25 Billion Settlement Over Monsanto's Roundup Cancer Claims In US ↗
Bayer AG (OTC: BAYRY) on Tuesday proposed a $7.25 billion settlement to resolve thousands of U.S. lawsuits claiming that its weedkiller Roundup causes cancer. The product was originally made by... 
Via Benzinga
Topics Lawsuit
News headline image
Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data
The multi-billion dollar wet Age-Related Macular Degeneration (wet AMD) market is standing on the precipice of a transformative shift. Today, February 16, 2026, Ocular Therapeutix (NASDAQ: OCUL) is in... 
Via MarketMinute
News headline image
Bayer® Aspirin Partners with Celebrity Chef Jeff Mauro for Immersive Dark Dining Experience This American Heart Month
From Bayer
Via Business Wire
News headline image
Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo
From Bayer
Via Business Wire
News headline image
Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL’ Campaign
From Bayer
Via Business Wire
News headline image
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
From Bayer
Via Business Wire
News headline image
Wall Street’s ‘Fear Gauge’ Reclaims the 20 Mark: Why the Greenland Tariff Threat and Earnings Redlining Triggered a Market Reset
The CBOE Volatility Index (VIX), often hailed as the stock market’s “fear gauge,” surged past the critical 20.00 threshold on January 20, 2026, marking a significant shift in investor sentiment as the... 
Via MarketMinute
Topics Economy Government Stocks
News headline image
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
From Bayer
Via Business Wire
News headline image
The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026
As of January 16, 2026, Moderna, Inc. (NASDAQ: MRNA) stands at a critical crossroads. Once the poster child for the biotechnology industry’s rapid response to a global pandemic, the Cambridge-based... 
Via Finterra
Topics Initial Public Offering Intellectual Property Lawsuit
News headline image
Bayer Accelerates Pharma Growth on High-Value Portfolio
From Bayer
Via Business Wire
News headline image
Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause
From Bayer
Via Business Wire
News headline image
Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
From Bayer
Via Business Wire
News headline image
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.